New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HomeNewsRegulatoryFDA reviewing safety of OTC cold medicines for children

FDA reviewing safety of OTC cold medicines for children

TAGS: Manufacturing and Supply (Business Resources) Manufacturer and Brand Regulatory
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
harvard-medical-school-promo.jpg
Harvard’s Pieter Cohen excoriates dietary supplement bill
May 02, 2022
Rubicon: Don’t Ignore Independent Waste Haulers in COVID-19 Relief
Senators propose mandatory listing of dietary supplements with FDA
Apr 28, 2022
Amazon logo
Supplements sector eyes Amazon after release of the FDA's NAC guidance
Apr 27, 2022
U.S. Food and Drug Administration buildings
FDA releases draft guidance on NAC supplements
Apr 21, 2022